Variant report
Variant | nsv818316 |
---|---|
Chromosome Location | chr5:12599348-12606091 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:14)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:14 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr5:12605684-12605760 | HepG2 | liver: | n/a | n/a |
2 | ATF1 | chr5:12599710-12599720 | K562 | blood: | n/a | n/a |
3 | CEBPB | chr5:12605701-12606007 | Hela-S3 | cervix: | n/a | chr5:12605883-12605894 chr5:12605840-12605851 |
4 | CEBPB | chr5:12605752-12606016 | HepG2 | liver: | n/a | chr5:12605883-12605894 chr5:12605840-12605851 |
5 | CEBPB | chr5:12605701-12606016 | A549 | lung: | n/a | chr5:12605883-12605894 chr5:12605840-12605851 |
6 | CEBPB | chr5:12605772-12605991 | K562 | blood: | n/a | chr5:12605883-12605894 chr5:12605840-12605851 |
7 | EP300 | chr5:12600151-12600186 | GM12878 | blood: | n/a | n/a |
8 | FOS | chr5:12605712-12605996 | MCF10A-Er-Src | breast: | n/a | n/a |
9 | FOS | chr5:12605778-12605908 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | JUND | chr5:12601754-12601891 | HepG2 | liver: | n/a | n/a |
11 | POLR2A | chr5:12603275-12603353 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | POLR2A | chr5:12600264-12600420 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | POLR2A | chr5:12605727-12606066 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | POLR2A | chr5:12605414-12605909 | K562 | blood: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:12588869..12590687-chr5:12605878..12607397,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000264921 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7449177 | chr5:12599348-12599349 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs147329824 | chr5:12599362-12599363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs555863637 | chr5:12599376-12599377 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs140980947 | chr5:12599412-12599413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs183241687 | chr5:12599421-12599422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs571041817 | chr5:12599454-12599455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs144620929 | chr5:12599473-12599474 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs557176964 | chr5:12599501-12599502 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs114004359 | chr5:12599551-12599552 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs562375338 | chr5:12599562-12599563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs372160931 | chr5:12599574-12599575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536562009 | chr5:12599575-12599576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs36057617 | chr5:12599580-12599581 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs554923426 | chr5:12599602-12599603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs573135247 | chr5:12599603-12599604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs147888566 | chr5:12599627-12599628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs568181835 | chr5:12599632-12599633 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs565369284 | chr5:12599689-12599690 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs59962327 | chr5:12599693-12599694 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs114932082 | chr5:12599694-12599695 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs188349335 | chr5:12599719-12599720 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs150649927 | chr5:12599723-12599724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs530797657 | chr5:12599778-12599779 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs58140912 | chr5:12599793-12599794 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs139980162 | chr5:12599799-12599800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs182316780 | chr5:12599812-12599813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs568649672 | chr5:12599840-12599841 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs528057484 | chr5:12599849-12599850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs546612619 | chr5:12599858-12599859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs148504961 | chr5:12599862-12599863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs554319616 | chr5:12599881-12599882 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs7449308 | chr5:12599885-12599886 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs72387963 | chr5:12599899-12599900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs201861769 | chr5:12599900-12599901 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs199679453 | chr5:12599906-12599907 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs201210170 | chr5:12599907-12599908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs7446112 | chr5:12599908-12599909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs373337459 | chr5:12599913-12599914 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs569132731 | chr5:12599918-12599919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs111438848 | chr5:12599924-12599925 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs554951577 | chr5:12599936-12599937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs561206521 | chr5:12599937-12599938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs10866497 | chr5:12600022-12600023 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs200183753 | chr5:12600045-12600046 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs200941344 | chr5:12600048-12600049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs201465404 | chr5:12600049-12600050 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs59196199 | chr5:12600051-12600052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs558996515 | chr5:12600095-12600096 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs577371860 | chr5:12600146-12600147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs544732544 | chr5:12600167-12600168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cervical squamous cell carcinoma | 21590768 | CNVD |
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cri-du chat syndrome | 16773131 | CNVD |
Cryptorchidism | 21048976 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Cervical cancer | 16585170 | CNVD |
Mental retardation | 16773131 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Cri-du chat syndrome | 22470819 | CNVD |
sporadic birth defects | 19047251 | CNVD |
Non-small cell lung cancer | 17643093 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Schizophrenia | 18940311 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Mental retardation | 17847001 | CNVD |
Neurocytoma | 17123091 | CNVD |
Mental retardation | 19546859 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Schizophrenia | 21346763 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:12598400-12610600 | Weak transcription | K562 | blood |
2 | chr5:12602000-12612400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr5:12602400-12602800 | Enhancers | Fetal Brain Male | brain |